FindTrial
Sign In

A STUDY OF TRIPHALA KWATH AND PANCHAVALKALA KWATH YONIKSHALANA IN MANAGEMENT OF SHWETAPRADARA

A Randomised comparitive study of Triphala kwath and Panchavalkala kwath Yonikshalana in management of Shwetapradara w.s.r Leucorrhoea - Nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/101619
Enrollment
60
Registered
2026-01-20
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Apurva tewatia
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Pateint with classical signs and symptoms of shwetapradar.

Exclusion criteria

Exclusion criteria: Patients with any diagnosed uterine or vaginal pathology like Uterine Fibroid, Adenomyosis, PID. If patient needs any other intervention. Patients with HIV, HCV, HbsAg. Patients with pregnancy and systemic illness like DM, HTN, COPD, etc

Design outcomes

Primary

MeasureTime frame
Reduction of shwetapradaraTimepoint: 10 days application with 15th day follow up—

Secondary

MeasureTime frame
Reduction in other symptoms of shwetapradara like yoni kand,yoni daurgandha,daurbalya.Timepoint: 15 days—

Countries

India

Contacts

Public ContactDr Hemlata sharma

Sanskriti ayurvedic medical college and hospital

dr.hemlatasharma08@gmail.com8390689769

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026